Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD) and is a significant risk factor for hospitalization and shortened life expectancy. Therefore, developing new serum biomarkers for early diagnosis and prognosis of COPD associated PH is crucial. In the present study, a solid-phase antibody array simultaneously detecting multiple proteins was used to search specific COPD associated PH biomarkers, with COPD patients and healthy subjects as control groups. As a result, compared to the COPD and healthy groups, the levels of MCP-4, SDF-1 alpha, CCL28, Adipsin, IL-28A, CD40 and AgRP were uniquely altered in COPD patient serum with pulmonary hypertension. Among these proteins, CCL28, MCP-4, CD40, AgRP and IL-28A were identified to be differentially expressed in COPD patients with hypertension, indicating that these cytokines may serve as novel biomarkers for the diagnosis and prognosis of COPD associated pulmonary hypertension.
Introduction
Pulmonary hypertension (PH) is primarily caused by chronic obstructive pulmonary disease (COPD), which is a global lung disease with high mortality and morbidity, and expected to be the fourth leading cause of death in the world in 2030 [1] . PH is an important factor for acute exacerbation of COPD and increases the hospitalization rate and the mortality of the patients with COPD [2] .
PH is characterized by pulmonary vascular remodeling, including medial hypertrophy, adventitial thickening, intimal proliferative changes, and fibrosis. Although right heart catheterization (RHC) is the gold standard for diagnosing and staging PH [3] , it is invasive and can be complicated with bleeding, pneumothorax, and other risks. RHC may not be widely available in patients with COPD. Clinically, Ultrasonic cardiogram (UCG) can be an effective measure to assess pulmonary artery systolic pressure. However, UCG has low sensitivity, specificity, and predictive values in patients with COPD mainly because the technical drawbacks in finding good windows [4, 5] . Thus far, PH remains a clinical dilemma with regard to accurate risk assessment and efficient management due to a lack of sufficient clinical or paraclinical variables for clinical decisions.
Biomarkers, involving normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention, are considered to be a useful, noninvasive tool for better diagnoses, accurate risk assessment, and appropriate management. Biomarkers are being increasingly recognized to have great clinical value. Recently, more and more studies have investigated specific PH medications in COPD [6] [7] [8] [9] [10] [11] [12] [13] with various inclusion criteria. However, the identification of specific PH biomarkers in COPD is rare. Therefore, identifying specific biomarkers for early diagnosis of COPD associated PH is urgently needed.
New, promising strategies for biomarker discovery include microarray assay and mass-spectrometry for the protein level detection [14] . However, mass-spectrometry suffers from high false positive rates and poor sensitivity. Antibody microarrays are a novel technology simultaneously detecting multiple proteins with the advantage of being high-throughput amenable [15] . The aim of the present study was to identify specific PH biomarkers to improve PH diagnosis and clinical https://doi.org/10.1016/j.cyto.2018.09.005 Received 20 March 2018; Received in revised form 9 September 2018; Accepted 11 September 2018 management in patients with COPD.
Materials and methods

Patients
6 COPD patients were recruited based on the Global Initiative for Chronic Obstructive Lung Disease criteria (Called COPD group). Another 6 COPD patients suffering from PH who were diagnosed by a right heart catheterization with a mean pulmonary artery pressure of 51-60 mmHg were also recruited (Named COPD+PH group). Patients who had causes of PH other than COPD were not enrolled in the study. 6 healthy volunteers with similar demographic characteristics were included as a control group. Subjects were from the Respiratory Department at the 2nd Affiliated Hospital of Guangzhou Medical University. Clinical data of the participants is listed in Table 1 . This study was approved by the Ethics Committee of the 2nd Affiliated Hospital of Guangzhou Medical University (2017-hs-09-01) and all participants signed written informed consent forms prior to their inclusion in the study.
Antibody array assay
Serum obtained from the participants was used to research specific PH biomarkers by Human Cytokine Antibody Array (GSH-CAA-440, RayBiotech Company, Norcross, GA, USA), according to the manufacturer's instructions. This antibody array simultaneously detects 440 cytokines in a single experiment by utilizing a sandwich technique with 440 antibody dots arranged in four duplicates printed onto the glass. Briefly, serum samples were diluted (1:2) and added into the array pools to incubate with capture antibodies overnight. After washing, the arrays were incubated with a biotin-conjugated anti-cytokine antibody mix for 2 h at room temperature. Cy3-conjugated streptavidin was added to bind with biotin from the detection antibodies and the fluorescent signal was detected using an InnoScan 300 Microarray Scanner (Innopsys, France). Signal values were captured with Mapix software. The data was normalized using positive control values from the array with the RayBiotech analysis tool, specifically designed to analyze the data of Human Cytokine Antibody Array G series 440 with Microsoft Excel technology.
ELISA
ELISA kits (RayBiotech, Norcross GA, USA) were utilized to validate the result of the antibody array, according to the manufacturer's instructions. Briefly, serum samples were diluted at different dilution factors based on individual serum biomarkers. Samples were coated on the plates overnight at 4°C. The plates were washed with wash buffer and biotin-conjugated antibody was added (1:80) into the ELISA plate for incubation (2 h). HRP-conjugated streptavidin was added (1:1000) to catalyze the TMB reagent. Finally, the catalytic reaction was stopped with the addition of sulfuric acid. For each step, each well was incubated at 100 μl. Finally, the OD 450 was determined using a microplate reader (ELx800NB, Biotek, Winooski, CT, USA).
RT-qPCR validation
Peripheral blood mononuclear cell (PBMC) were isolated from whole blood collected from COPD+PH, COPD and control using FicollHypaque (Lonza, Walkersville, MD). Total RNA was extracted from PBMC using the Trizol method (Life Technologies, Carlsbad, California), then was reverse-transcribed using SuperScriptIII reverse transcriptase (first Strand Kit; Invitrogen, Carlsbad, CA), a mixture of random hexamers and specific primers (MCP-4, Forward primer (5′ to 3′): ATGTGATCACCACCAG CAGG. Reverse primer (5′ to 3′): ATTCTG GACCCACTT CTCCT; CCL28, Forward primer (5′ to 3′): 5′-CAGAGAG Severity of PH (mmHg): mild (41-50), moderate (51-60), severe > 60. There is no significant difference in age among the three groups. Severity of PH (mmHg): mild (41-50), moderate (51-60), severe > 60. There is no significant difference in age among the three groups. Fig. 1 . Venn diagram analysis. The differentially expressed proteins between the COPD+PH, COPD and healthy control groups were analyzed by Venn diagram to identify specific COPD associated PH biomarkers. GACTCGCCATCGT-3′. Reverse primer (5′ to 3′): 5′-TGTGAAACCTCCG TGCAACA-3′). PCR amplification of MCP-4 and CCL28 was performed with SYBR® Select Master Mix (Applied Biosystems, Foster City, CA, USA) and the Applied Biosystems 7500 Fast real-time PCR system. The housekeeping gene β-actin was used to normalize the gene expression levels of MCP-4 and CCL28 (Forward primer 5′ to 3′: CTCCATCCTGG CCTCGCTGT. Reverse primer 5′ to 3′: GCTGTCACCTTCACCGTTCC). The ΔΔCT method was used to calculate relative expression levels.
Bio-informatics analysis
To clarify the potential functions of COPD associated PH specific biomarkers in the pathogenesis of COPD associated PH, the gene ontology (GO) and pathway analysis, using KOBAS3.0 database (http:// kobas.cbi.pku.edu.cn/index.php), were utilized to describe the biological processes, cellular components and molecular functions of these proteins with their normalized array data and their gene IDs. Proteinprotein interaction (PPI) analysis was performed to search node proteins using String database (https://string-db.org/cgi/input.pl) and their protein IDs.
Statistical analysis
Statistical analyses were performed using SPSS v20 (IBM Corp., Armonk, NY, USA). Comparisons between groups were performed by one-way ANOVA followed by multiple comparisons performed with post hoc Bonferroni test. Differences were considered statistically significant when the P values were < 0.05. All data were shown as mean ± SD. In addition, fold change (FC) between groups was calculated to indicate the relative expression levels of the cytokines.
Results
Specific COPD associated PH biomarker analysis
In order to identify COPD associated PH specific biomarkers, the differential proteins were statistically analyzed using post hoc Bonferroni test between any two groups among the COPD+PH, COPD and control groups. As a result, 143 cytokines differentially expressed between COPD and the control groups were identified, 133 proteins between the COPD+PH and control groups were identified, and 31 factors between the COPD+PH and COPD subjects were found (detailed data in supplementary Table S1 ). The specific COPD associated PH biomarkers were the proteins differentially expressed in COPD+PH vs COPD and COPD+PH vs control, but not differentially expressed between the COPD and control groups. Therefore, after the Venn diagram analysis, we identified 7 specific COPD associated PH biomarkers (Fig. 1) . 
Expression characteristics of COPD associated PH biomarkers
The information of seven specific COPD associated PH biomarkers, including MCP-4, CD40, SDF-1 alpha, CCL28, Adipsin (CFD), AgRP and IL-28A, presents in Table 3 , and their expression levels were further analyzed by boxplot display using the signal values. As shown in Fig. 2 , MCP-4, SDF-1 alpha, CCL28, Adipsin, and IL-28A were increased, while CD40 and AgRP were decreased in COPD+PH serum as compared to the COPD and control groups. Additionally, their array profiles with fluorescent intensities positively relevant to the expression levels are shown in Fig. 3 , further revealing the variations of these seven proteins in COPD+PH. Moreover, an unsupervised-hierarchical cluster could distinguish COPD+PH group from the other two groups with 83.3% accuracy using the array signal values of these seven proteins (Fig. 4) .
Validation array results with ELISA
To validate the specific COPD associated PH biomarkers, additional samples including 19 control cases, 20 COPD individuals and 20 COPD +PH samples were analyzed via ELISA and RT-qPCR. The clinical information of the participants is listed in Table 2 . Among these seven COPD associated PH biomarkers, three (MCP-4, CCL28 and CD40) were chose for ELISA validation and two (MCP-4 and CCL28) for RT-qPCR validation due to the limited sample volume. The levels of these cytokines obtained from ELISA and RT-qPCR results were consistent with array results, conforming the expression differences between the COPD+PH and the COPD or control groups (Figs. 5 and 6 ).
Bioinformatics analysis
The bioinformatics analysis results the eight most enriched pathways are cytokine-cytokine receptor interaction, intestinal immune network for IgA production, chemokine receptors bind chemokines, NFkappa B signaling pathway, chemokine signaling pathway, peptide ligand-binding receptors, class A/1 (Rhodopsin-like receptors), GPCR ligand binding (Fig. 7) . The eleven most common GO terms are extracellular space, extracellular region part, extracellular region, positive regulation of biological process, response to stimulus regulation of biological process, regulation of biological process, biological regulation, single-organism cellular process, single-organism process, cellular process, cell (supplementary Fig. S1 ). Fig. 8 shows the interaction relationships of those seven differential proteins.
Discussion
PH is characterized by pulmonary vascular remodeling, including parenchymal destruction and lung vessel loss, and is associated with a high resistance to blood flow in the lung [16] , which will deteriorate Fig. 3 . The COPD associated PH serum biomarker profiles. In the profiles of antibody arrays, the levels of cytokines are proportional to their fluorescence intensity. In these arrays, each antibody was printed in four duplicates, and the locations of the serum COPD associated PH biomarkers are noted in colored boxes. the function of heart and lung and increases the risk of hospitalization and death [17] . However, the pathogenic mechanisms that lead to pulmonary vascular resistance in COPD are complex and remain unclear. Most COPD patients with PH experience no symptoms in the early stage, and the onset of symptoms indicates end-stage disease with poor outcomes and prognoses. Early diagnosis of PH helps rapid decisionmaking and treatment, which improves the outcomes in patients with COPD. Thus, it is necessary to diagnose PH early in COPD. Clinically, ultrasonic cardiogram (UCG) can be an effective measure to assess pulmonary artery systolic pressure, but UCG has low sensitivity, specificity, and predictive values in patients with COPD [4, 5] .
Biomarkers are extensively utilized to estimate the severity of inflammation in COPD patients and novel markers increasingly are being identified to assist in predicting the PH prognosis in COPD [18] . In the present study, the protein array detection identified seven serum COPD associated PH biomarkers, such as MCP-4, CD40, SDF-1 alpha, CCL28, Adipsin, AgRP and IL-28A. Furthermore, the unsupervised-hierarchical cluster analysis confirmed the difference, with 83.3% accuracy, of the seven proteins between the COPD+PH and the two groups.
To understand better these differentially expressed factors in COPD associated PH, pathway and GO analyses were used to reveal their potential biological functions. Among the 8 most enriched pathways, cytokine-cytokine receptor interaction and chemokine signaling pathways have been reported to be related to the pathogenesis of COPD associated PH [19] . The NF-κB pathway is an inflammation pathway, activation of which can promote vascular inflammation [20] . A previous study reported that NF-κB inhibition could reduce lung vascular lumen obliteration in severe pulmonary hypertension in rats [21] . In the report, class A/1, rhodopsin-like G protein-coupled receptors (GPCR) play important roles in the occurrence and development of pulmonary arterial hypertension, further suggesting class A/1 (Rhodopsin-like receptors) and GPCR ligand binding pathways are relevant to COPD associated PH [22] . Based on bioinformatic analysis and previous studies, it is likely that the COPD associated PH is developed by the activation of these pathways. Furthermore, the 11 most enriched GO terms illuminate that these seven proteins participate mainly in positive regulation of biological process in the extracellular region, suggesting these proteins may abnormally regulate the cellular biological process to cause the development of COPD associated PH due to their differential expression. Finally, PPI analysis showed SDF-1a (CXCL12) as a node protein that was related with CCL28, MCP-4 (CCL13) and CD40, suggesting these four targets might regulate the pathogenesis of COPD associated PH.
SDF-1a is a potent pro-angiogenic chemokine and is regulated by NF-κB. Previous evidence demonstrated that SDF-1aplays an important role in the pathogenesis of PH by binding with CXCR4 and CXCR7 [23] [24] [25] . Elevated plasma SDF-1ais associated with a poorer prognosis in pulmonary arterial hypertension [26] . Consistently, plasma SDF-1a in PH was also elevated in the present study. CCL28 is a CC chemokine, a ligand for CCR10. It was found that CCL28 expression was increased in some asthmatic patients [27] . However, there had not been reports about CCL28 expression alteration or role in COPD associated PH. In the present study, it was shown that serum CCL28 was elevated in COPD associated PH patients. Similarly, MCP-4, also a CC chemokine, was significantly up-regulated in patients with asthma [28] , and was found to be increased in COPD associated PH serum in the present study as well, suggesting good candidates for COPD associated PH diagnostic markers. CD40, initially known as a leukocyte surface antigen, was also found in other cell types, such as endothelial cells, fibroblasts, and dendritic cells [29] [30] [31] . Li et al. reported that CD40 was highly expressed in pulmonary adventitial fibroblasts under hypoxic hypertension [32] . However, the present study showed that the CD40 level was Fig. 4 . Unsupervised-hierarchical cluster analysis. The array data of COPD associated PH biomarkers was used for unsupervised-hierarchical cluster analysis using R software. Green indicates low levels of the proteins, black for median levels, and red for high levels. decreased in COPD associated PH. Recently, Kusters et al. found that constitutive activation of CD40 in dendritic cells attenuated atherosclerosis by impairing lipid uptake [33] . Atherosclerosis is the major cause of mortality and significant morbidity in hypertension. Dyslipidemia, hyperinsulinemia increases risk of vascular atherosclerosis, further develop hypertension [34] . Therefore, decreased CD40 may promote the progression of COPD associated PH, and CD40 may be developed as a drug for treating COPD associated PH. Adipsin, a serine protease, is a protein abundantly secreted in fat tissues. Korman et al. reported that elevated adipsin levels were associated with pulmonary arterial hypertension in systemic sclerosis [35] . Similarly, adipsin levels were also found to be increased in COPD associated PH without systemic sclerosis in our study, further illuminating the possibility that adipsin may promote the progression of COPD associated PH. AgRP (agouti-related protein) is an orexigenic neuropeptide that promotes food intake and weight gain and is localized in neurons [36] . However, there have not been reports about the association of AgRP with COPD associated PH. In the present study, we found AgRP was decreased in PH, suggesting that AgRP may play a role against the progression of COPD associated PH, but the detailed mechanism against COPD 6 . The validation results of serum COPD associated PH biomarkers by RT-qPCR. Relative mRNA expression levels of MCP-4 and CCL28 in PBMC were examined by RT-qPCR. The ΔΔCT method was used to calculate relative expression levels. *p < 0.05 versus COPD+PH group. # p > 0.05 versus control group. associated PH requires further research. IL-28A is known to induce antiviral activity [37, 38] , but there are few reports regarding IL-28A regulating lung function. Travar et al. revealed that IL-28A levels in the sputum of patients with pulmonary tuberculosis were significantly elevated [39] , and our study is the first to measure elevated IL-28A in COPD associated PH patient serum.
Interestingly, we found that there are fifty proteins with significant higher levels in both COPD and COPD+PH patients as compared to the controls (supplementary Table S2 ), suggesting that these proteins may promote the occurrence and development of COPD and COPD associated PH, targeting these proteins at lower expression levels could be a new strategy to treat COPD and COPD associated PH, which needs further investigation.
In conclusion, in the present study, we found seven specific COPD associated PH serum biomarkers, using COPD and healthy individuals as control. Five of these seven COPD associated PH biomarkers, CCL28, MCP-4, CD40, AgRP and IL-28A, are reported for the first time in this study. However, additional studies with large clinical sample sizes are required to further explore their usefulness in diagnosis and prognosis in COPD associated PH. Fig. 7 . Pathway analysis. The eight most enriched pathways with the smallest corrected p-value less than 0.05 were shown. Fig. 8 . PPI analysis. The serum COPD associated PH biomarkers were performed for the PPI analysis. The line between two protein means that there is correlation with these two proteins in the biological function and the line thickness indicates the strength of data support.
